• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心房心肌病:房颤卒中预防中未被探索的魏尔啸氏三联征分支。

Atrial Cardiomyopathy: An Unexplored Limb of Virchow's Triad for AF Stroke Prophylaxis.

作者信息

Darlington Ashley, McCauley Mark D

机构信息

Division of Cardiology, Department of Medicine, College of Medicine, University of Illinois at Chicago, Chicago, IL, United States.

Jesse Brown VA Medical Center, Chicago, IL, United States.

出版信息

Front Cardiovasc Med. 2020 Feb 18;7:11. doi: 10.3389/fcvm.2020.00011. eCollection 2020.

DOI:10.3389/fcvm.2020.00011
PMID:32133372
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7039862/
Abstract

The most dreaded complication of atrial fibrillation is stroke, and 70-80% of patients with AF-related stroke die or become disabled. The mechanisms of thromboembolism in AF are multifactorial, with evidence demonstrating that all three criteria of Virchow's triad are satisfied in AF: abnormal stasis of blood, endothelial damage, and hypercoagulability. Mechanistic insights into the latter two limbs have resulted in effective stroke prophylactic therapies (left atrial appendage occlusion and oral anticoagulants); however, despite these advances, there remains an excess of stroke in the AF population that may be due, in part, to a lack of mechanistic understanding of atrial hypocontractility resulting in abnormal stasis of blood within the atrium. These observations support the emerging concept of atrial cardiomyopathy as a cause of stroke. In this Review, we evaluate molecular, translational, and clinical evidence for atrial cardiomyopathy as a cause for stroke from AF, and present a rationale for further investigation of this largely unaddressed limb of Virchow's triad in AF.

摘要

心房颤动最可怕的并发症是中风,70%-80%的房颤相关性中风患者会死亡或致残。房颤血栓栓塞的机制是多因素的,有证据表明房颤满足了魏尔啸氏三联征的所有三个标准:血液异常淤滞、内皮损伤和高凝状态。对后两个因素的机制性认识带来了有效的中风预防疗法(左心耳封堵和口服抗凝药);然而,尽管有这些进展,房颤人群中仍有过多的中风病例,这可能部分归因于对心房收缩功能减退导致心房内血液异常淤滞缺乏机制性认识。这些观察结果支持了心房心肌病作为中风病因这一新兴概念。在本综述中,我们评估了心房心肌病作为房颤所致中风病因的分子、转化和临床证据,并提出了进一步研究房颤中魏尔啸氏三联征这一基本未被关注因素的理论依据。

相似文献

1
Atrial Cardiomyopathy: An Unexplored Limb of Virchow's Triad for AF Stroke Prophylaxis.心房心肌病:房颤卒中预防中未被探索的魏尔啸氏三联征分支。
Front Cardiovasc Med. 2020 Feb 18;7:11. doi: 10.3389/fcvm.2020.00011. eCollection 2020.
2
Imaging and biophysical modelling of thrombogenic mechanisms in atrial fibrillation and stroke.心房颤动与中风中血栓形成机制的成像及生物物理建模
Front Cardiovasc Med. 2023 Jan 16;9:1074562. doi: 10.3389/fcvm.2022.1074562. eCollection 2022.
3
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited.心房颤动中血栓形成的机制:重温魏尔啸氏三要素。
Lancet. 2009 Jan 10;373(9658):155-66. doi: 10.1016/S0140-6736(09)60040-4.
4
[Is Atrial Fibrillation a Pre-Thrombotic State?].[心房颤动是一种血栓前状态吗?]
Rinsho Byori. 2015 Dec;63(12):1427-34.
5
The prothrombotic state in atrial fibrillation: pathophysiological and management implications.心房颤动中的血栓前状态:病理生理和管理意义。
Cardiovasc Res. 2019 Jan 1;115(1):31-45. doi: 10.1093/cvr/cvy272.
6
Female sex as an independent risk factor for stroke in atrial fibrillation: possible mechanisms.女性性别作为心房颤动患者中风的独立危险因素:可能的机制
Thromb Haemost. 2014 Mar 3;111(3):385-91. doi: 10.1160/TH13-04-0347. Epub 2013 Dec 5.
7
Molecular basis of thromboembolism in association with atrial fibrillation.与心房颤动相关的血栓栓塞的分子基础。
Circ J. 2007;71 Suppl A:A40-4. doi: 10.1253/circj.71.a40.
8
The endothelium and atrial fibrillation. The prothrombotic state revisited.内皮与心房颤动。再探血栓前状态。
Hamostaseologie. 2008 Oct;28(4):207-12.
9
Atrial fibrillation and the prothrombotic state: revisiting Virchow's triad in 2020.心房颤动与血栓前状态:2020 年再探维柯氏三联征。
Heart. 2020 Oct;106(19):1463-1468. doi: 10.1136/heartjnl-2020-316977. Epub 2020 Jul 16.
10
[Mechanism and risk factors of cardiogenic thromboembolism in patients with atrial fibrillation].[心房颤动患者心源性血栓栓塞的机制及危险因素]
Nihon Rinsho. 2013 Jan;71(1):36-40.

引用本文的文献

1
Immune Regulation in Atrial Cardiomyopathy.心房心肌病中的免疫调节
Rev Cardiovasc Med. 2025 Apr 30;26(5):26897. doi: 10.31083/RCM26897. eCollection 2025 May.
2
Fibrinaloid Microclots and Atrial Fibrillation.纤维蛋白样微血栓与心房颤动
Biomedicines. 2024 Apr 17;12(4):891. doi: 10.3390/biomedicines12040891.
3
Genetic variants, pathophysiological pathways, and oral anticoagulation in patients with hypertrophic cardiomyopathy and atrial fibrillation.肥厚型心肌病合并心房颤动患者的基因变异、病理生理途径与口服抗凝治疗

本文引用的文献

1
The Role of Cardiovascular and Metabolic Comorbidities in the Link between Atrial Fibrillation and Cognitive Impairment: An Appraisal of Current Scientific Evidence.心血管和代谢合并症在心房颤动与认知障碍之间的关联中的作用:对当前科学证据的评估。
Medicina (Kaunas). 2019 Nov 30;55(12):767. doi: 10.3390/medicina55120767.
2
Thrombin Induces Angiotensin II-Mediated Senescence in Atrial Endothelial Cells: Impact on Pro-Remodeling Patterns.凝血酶诱导心房内皮细胞中血管紧张素II介导的衰老:对促重构模式的影响。
J Clin Med. 2019 Oct 1;8(10):1570. doi: 10.3390/jcm8101570.
3
Disease-treatment interactions in the management of patients with obesity and diabetes who have atrial fibrillation: the potential mediating influence of epicardial adipose tissue.
Front Cardiovasc Med. 2023 Apr 17;10:1023394. doi: 10.3389/fcvm.2023.1023394. eCollection 2023.
4
Atrial Fibrillation, thromboembolic risk, and the potential role of the natriuretic peptides, a focus on BNP and NT-proBNP - A narrative review.心房颤动、血栓栓塞风险与利钠肽的潜在作用,聚焦于脑钠肽和N末端脑钠肽原——一篇叙述性综述
Int J Cardiol Heart Vasc. 2022 Oct 10;43:101132. doi: 10.1016/j.ijcha.2022.101132. eCollection 2022 Dec.
5
Atrial cardiomyopathy: from cell to bedside.心房心肌病:从细胞到床边。
ESC Heart Fail. 2022 Dec;9(6):3768-3784. doi: 10.1002/ehf2.14089. Epub 2022 Aug 3.
6
Neurological Manifestations of Myocarditis.心肌炎的神经系统表现。
Curr Neurol Neurosci Rep. 2022 Jul;22(7):363-374. doi: 10.1007/s11910-022-01203-9. Epub 2022 May 19.
7
Latest Insights into Mechanisms behind Atrial Cardiomyopathy: It Is Not always about Ventricular Function.心房心肌病背后机制的最新见解:并非总是与心室功能有关。
Diagnostics (Basel). 2021 Mar 5;11(3):449. doi: 10.3390/diagnostics11030449.
8
Enrichment of loss-of-function and copy number variants in ventricular cardiomyopathy genes in 'lone' atrial fibrillation.“孤立性”心房颤动中室性心肌病基因的功能丧失和拷贝数变异的富集。
Europace. 2021 Jun 7;23(6):844-850. doi: 10.1093/europace/euaa421.
肥胖和糖尿病合并心房颤动患者管理中的疾病-治疗相互作用:心外膜脂肪组织的潜在中介影响。
Cardiovasc Diabetol. 2019 Sep 24;18(1):121. doi: 10.1186/s12933-019-0927-9.
4
Epicardial Adipose Tissue Inflammation Can Cause the Distinctive Pattern of Cardiovascular Disorders Seen in Psoriasis.心外膜脂肪组织炎症可导致银屑病患者出现独特的心血管疾病模式。
Am J Med. 2020 Mar;133(3):267-272. doi: 10.1016/j.amjmed.2019.08.027. Epub 2019 Sep 11.
5
Rs4968309 in Myosin Light Chain 4 (MYL4) Associated With Atrial Fibrillation Onset and Predicts Clinical Outcomes After Catheter Ablation in Atrial Fibrillation Patients Without Structural Heart Disease.MYL4 基因中的 rs4968309 与无结构性心脏病的房颤患者导管消融术后房颤发作及临床结局相关
Circ J. 2019 Sep 25;83(10):1994-2001. doi: 10.1253/circj.CJ-19-0415. Epub 2019 Aug 10.
6
Regional isolation in the right atrium with disruption of intra-atrial conduction after catheter ablation of atrial tachycardia.右心房局部隔离伴房间内传导中断在心房速导管消融术后。
J Cardiovasc Electrophysiol. 2019 Oct;30(10):1773-1785. doi: 10.1111/jce.14037. Epub 2019 Jul 9.
7
Left Atrial Stiffness, a Marker of Atrial Cardiomyopathy, and Atrial Fibrillation - Relationships and Predictors for Procedure Success after Catheter Ablation.左心房僵硬度,一种心房心肌病的标志物,与心房颤动——导管消融术后手术成功的关系及预测因素
Arq Bras Cardiol. 2019 Jun 6;112(5):509-510. doi: 10.5935/abc.20190087.
8
Electrocardiographic evidence of abnormal atrial phenotype in Brugada syndrome.
J Electrocardiol. 2019 Jul-Aug;55:102-106. doi: 10.1016/j.jelectrocard.2019.05.005. Epub 2019 May 13.
9
Effect of catheter ablation on pre-existing abnormalities of left atrial systolic, diastolic, and neurohormonal functions in patients with chronic heart failure and atrial fibrillation.导管消融对慢性心力衰竭伴心房颤动患者左心房收缩、舒张和神经激素功能的预先存在异常的影响。
Eur Heart J. 2019 Jun 14;40(23):1873-1879. doi: 10.1093/eurheartj/ehz284.
10
Identification of the A293 (AVE1231) Binding Site in the Cardiac Two-Pore-Domain Potassium Channel TASK-1: a Common Low Affinity Antiarrhythmic Drug Binding Site.心脏双孔结构域钾通道TASK-1中A293(AVE1231)结合位点的鉴定:一个常见的低亲和力抗心律失常药物结合位点。
Cell Physiol Biochem. 2019;52(5):1223-1235. doi: 10.33594/000000083.